Inflammatory Arthritis Clinical Trials
3 recruiting trials for Inflammatory Arthritis. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Inflammatory Arthritis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Extremity Medical (1), The Danish Center for Expertise in Rheumatology (1), McGill University Health Centre/Research Institute of the McGill University Health Centre (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is KinematX total wrist arthroplasty system (device, 1 trial), followed by COMFI - a COMbined Fatigue Intervention, MedSafer deprescribing opportunity reports, EMPOWER brochures.
Track Inflammatory Arthritis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The KinematX Midcarpal Total Wrist Arthroplasty Registry
The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist...
COMFI - a COMbined Fatigue Intervention
Background: Inflammatory arthritis (IA) encompasses autoimmune rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Fatigue is...
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for patients, can help to...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Inflammatory Arthritis, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Inflammatory Arthritis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Inflammatory Arthritis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.